IBDEI0Z2 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17095,1,4,0)
 ;;=4^V79.3
 ;;^UTILITY(U,$J,358.3,17095,1,5,0)
 ;;=5^SCREEN-DEVELOPMENT PROB
 ;;^UTILITY(U,$J,358.3,17095,2)
 ;;=^295680
 ;;^UTILITY(U,$J,358.3,17096,0)
 ;;=V79.8^^88^1045^2
 ;;^UTILITY(U,$J,358.3,17096,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17096,1,4,0)
 ;;=4^V79.8
 ;;^UTILITY(U,$J,358.3,17096,1,5,0)
 ;;=5^SCREEN-MENTAL DIS NEC
 ;;^UTILITY(U,$J,358.3,17096,2)
 ;;=^295681
 ;;^UTILITY(U,$J,358.3,17097,0)
 ;;=V10.00^^88^1046^9
 ;;^UTILITY(U,$J,358.3,17097,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17097,1,4,0)
 ;;=4^V10.00
 ;;^UTILITY(U,$J,358.3,17097,1,5,0)
 ;;=5^HX OF GI MALIGNANCY NOS
 ;;^UTILITY(U,$J,358.3,17097,2)
 ;;=^295202
 ;;^UTILITY(U,$J,358.3,17098,0)
 ;;=V10.01^^88^1046^21
 ;;^UTILITY(U,$J,358.3,17098,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17098,1,4,0)
 ;;=4^V10.01
 ;;^UTILITY(U,$J,358.3,17098,1,5,0)
 ;;=5^HX OF TONGUE MALIGNANCY
 ;;^UTILITY(U,$J,358.3,17098,2)
 ;;=^295203
 ;;^UTILITY(U,$J,358.3,17099,0)
 ;;=V10.02^^88^1046^38
 ;;^UTILITY(U,$J,358.3,17099,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17099,1,4,0)
 ;;=4^V10.02
 ;;^UTILITY(U,$J,358.3,17099,1,5,0)
 ;;=5^HX-ORAL/PHARYNX MALG NEC
 ;;^UTILITY(U,$J,358.3,17099,2)
 ;;=^295204
 ;;^UTILITY(U,$J,358.3,17100,0)
 ;;=V10.03^^88^1046^25
 ;;^UTILITY(U,$J,358.3,17100,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17100,1,4,0)
 ;;=4^V10.03
 ;;^UTILITY(U,$J,358.3,17100,1,5,0)
 ;;=5^HX-ESOPHAGEAL MALIGNANCY
 ;;^UTILITY(U,$J,358.3,17100,2)
 ;;=^295205
 ;;^UTILITY(U,$J,358.3,17101,0)
 ;;=V10.04^^88^1046^7
 ;;^UTILITY(U,$J,358.3,17101,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17101,1,4,0)
 ;;=4^V10.04
 ;;^UTILITY(U,$J,358.3,17101,1,5,0)
 ;;=5^HX OF GASTRIC MALIGNANCY
 ;;^UTILITY(U,$J,358.3,17101,2)
 ;;=^295206
 ;;^UTILITY(U,$J,358.3,17102,0)
 ;;=V10.05^^88^1046^5
 ;;^UTILITY(U,$J,358.3,17102,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17102,1,4,0)
 ;;=4^V10.05
 ;;^UTILITY(U,$J,358.3,17102,1,5,0)
 ;;=5^HX OF COLONIC MALIGNANCY
 ;;^UTILITY(U,$J,358.3,17102,2)
 ;;=^295207
 ;;^UTILITY(U,$J,358.3,17103,0)
 ;;=V10.06^^88^1046^40
 ;;^UTILITY(U,$J,358.3,17103,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17103,1,4,0)
 ;;=4^V10.06
 ;;^UTILITY(U,$J,358.3,17103,1,5,0)
 ;;=5^HX-RECTAL ANAL MALIGN
 ;;^UTILITY(U,$J,358.3,17103,2)
 ;;=^295208
 ;;^UTILITY(U,$J,358.3,17104,0)
 ;;=V10.07^^88^1046^13
 ;;^UTILITY(U,$J,358.3,17104,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17104,1,4,0)
 ;;=4^V10.07
 ;;^UTILITY(U,$J,358.3,17104,1,5,0)
 ;;=5^HX OF LIVER MALIGNANCY
 ;;^UTILITY(U,$J,358.3,17104,2)
 ;;=^295209
 ;;^UTILITY(U,$J,358.3,17105,0)
 ;;=V10.09^^88^1046^8
 ;;^UTILITY(U,$J,358.3,17105,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17105,1,4,0)
 ;;=4^V10.09
 ;;^UTILITY(U,$J,358.3,17105,1,5,0)
 ;;=5^HX OF GI MALIGNANCY NEC
 ;;^UTILITY(U,$J,358.3,17105,2)
 ;;=^295210
 ;;^UTILITY(U,$J,358.3,17106,0)
 ;;=V10.11^^88^1046^22
 ;;^UTILITY(U,$J,358.3,17106,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17106,1,4,0)
 ;;=4^V10.11
 ;;^UTILITY(U,$J,358.3,17106,1,5,0)
 ;;=5^HX-BRONCHOGENIC MALIGNAN
 ;;^UTILITY(U,$J,358.3,17106,2)
 ;;=^295211
 ;;^UTILITY(U,$J,358.3,17107,0)
 ;;=V10.12^^88^1046^44
 ;;^UTILITY(U,$J,358.3,17107,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17107,1,4,0)
 ;;=4^V10.12
 ;;^UTILITY(U,$J,358.3,17107,1,5,0)
 ;;=5^HX-TRACHEAL MALIGNANCY
 ;;^UTILITY(U,$J,358.3,17107,2)
 ;;=^295212
 ;;^UTILITY(U,$J,358.3,17108,0)
 ;;=V10.20^^88^1046^41
 ;;^UTILITY(U,$J,358.3,17108,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17108,1,4,0)
 ;;=4^V10.20
 ;;^UTILITY(U,$J,358.3,17108,1,5,0)
 ;;=5^HX-RESP ORG MALIGNAN NOS
 ;;^UTILITY(U,$J,358.3,17108,2)
 ;;=^295213
 ;;
 ;;$END ROU IBDEI0Z2
